Recombinant Human MYL9 Protein，His

MYL9, or Myosin Light Chain 9, is a key component of the cytoskeletal system, primarily involved in muscle contraction and cellular motility. Research into MYL9 has gained significant attention due to its role in regulating smooth muscle contraction, endothelial function, and various cellular processes, including cytokinesis and cell adhesion. The protein is a critical part of the myosin complex, where it interacts with myosin heavy chains to regulate the contractile activity of non-muscle cells. Alterations in MYL9 expression and function have been implicated in various diseases, including cardiovascular conditions, cancer metastasis, and other pathologies characterized by aberrant cell movement and contractility. Understanding MYL9 at the molecular level through recombinant protein studies is essential for elucidating its functional mechanisms and potential therapeutic targets. This research often involves the expression of MYL9 using recombinant DNA technology to produce the protein in various expression systems, facilitating subsequent functional assays and structural analyses. These studies pave the way for novel interventions aimed at modulating MYL9 activity, with implications for treating conditions associated with dysfunctional cytoskeletal dynamics. Overall, the investigation of MYL9 recombinant protein contributes significantly to our understanding of cellular mechanics and the potential development of targeted therapies in multi-faceted diseases.